Brixadi (buprenorphine) Subcutaneous Injection, 24 mg Weekly Prefilled Syringe, 0.48 mL, Each
Brixadi is a subcutaneous injection containing buprenorphine, indicated for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 24 mg weekly dose in a 0.48 mL volume, providing a convenient, ready-to-use option for healthcare professionals. Each syringe is individually packaged for single-dose administration.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a subcutaneous injection containing buprenorphine, indicated for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 24 mg weekly dose in a 0.48 mL volume, providing a convenient, ready-to-use option for healthcare professionals. Each syringe is individually packaged for single-dose administration.
1 vendor
